Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitus
in Endocrine ConnectionsSearch for other papers by Marenao Tanaka in
Current site
Google Scholar
PubMed
Search for other papers by Tomohito Gohda in
Current site
Google Scholar
PubMed
Search for other papers by Nozomu Kamei in
Current site
Google Scholar
PubMed
Search for other papers by Maki Murakoshi in
Current site
Google Scholar
PubMed
Search for other papers by Tatsuya Sato in
Current site
Google Scholar
PubMed
Search for other papers by Mitsunobu Kubota in
Current site
Google Scholar
PubMed
Search for other papers by Michiyoshi Sanuki in
Current site
Google Scholar
PubMed
Search for other papers by Erika Ishiwata in
Current site
Google Scholar
PubMed
Search for other papers by Keisuke Endo in
Current site
Google Scholar
PubMed
Search for other papers by Yusuke Suzuki in
Current site
Google Scholar
PubMed
Search for other papers by Masato Furuhashi in
Current site
Google Scholar
PubMed
Background: Fatty acid-binding protein 4 (FABP4) is an adipokine that plays significant roles in the development of insulin resistance and atherosclerosis. High levels of soluble tumor necrosis factor receptors (TNFRs) including TNFR1 and TNFR2 are associated with renal dysfunction and increased mortality in patients with diabetes mellitus (DM). However, the association between circulating levels of FABP4 and TNFRs remains unclear.
Methods: We investigated the associations of FABP4 with TNFRs and metabolic markers in Japanese patients with type 1 DM (T1DM, n=76, men/women: 31/45) and type 2 DM (T2DM, n=575, men/women: 312/263).
Results: FABP4 concentration was positively correlated with levels of TNFR1 and TNFR2 in both patients with T1DM and those with T2DM. Multivariable regression analyses showed that there were independent associations of FABP4 concentration with body mass index (BMI) and estimated glomerular filtration rate (eGFR) after adjustment of age and sex in both patients with T1DM and those with T2DM. FABP4 concentration was independently associated with circulating levels of TNFR1 and TNFR2 after adjustment of the confounders in patients with T2DM but not in those with T1DM. Similarly, levels of TNFR1 and TNFR2 were independently associated with FABP4 concentration after adjustment of age, sex, systolic blood pressure, duration of DM and levels of eGFR, high-density lipoprotein cholesterol and C-reactive protein in patients with T2DM but not in those with T1DM.
Conclusion: FABP4 concentration is independently associated with levels of TNFRs in patients with DM, but the association is more evident in patients with T2DM than in those with T1DM.
Endocrine Connections is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
As an open-access journal, Endocrine Connections articles are immediately available to read on publication, without restriction. The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 767 | 767 | 631 |
| PDF Downloads | 183 | 183 | 156 |
Online ISSN: 2049-3614
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519